Neonatal effects of nifedipine and ritodrine for preterm labor

Obstetrics and Gynecology

Volumn 95, Issue 4, 2000, Pages 477-481

  Papatsonis, D N M ^a   Kok, J H ^a   Van Geijn, H P ^a   Bleker, O P ^a   Ader H J ^b   Dekker, G A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; LUNG SURFACTANT; NIFEDIPINE; RITODRINE; STEROID;

ADULT; ANXIETY NEUROSIS; APGAR SCORE; ARTICLE; BLOOD PH; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; ENCEPHALOMALACIA; FEMALE; GESTATIONAL AGE; HEADACHE; HOSPITALIZATION; HUMAN; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MEMBRANE RUPTURE; MENINGITIS; MULTICENTER STUDY; NAUSEA; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN JAUNDICE; NEWBORN MORBIDITY; NEWBORN MORTALITY; PATENT DUCTUS ARTERIOSUS; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RESPIRATORY DISTRESS SYNDROME; RISK FACTOR; SEPSIS; SUSTAINED RELEASE FORMULATION; TACHYCARDIA; TOCOLYSIS; TREATMENT OUTCOME; UMBILICAL ARTERY; VOMITING;

ADULT; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; NIFEDIPINE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RITODRINE; TOCOLYTIC AGENTS;

EID: 0034009349     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00596-7     Document Type: Article

References (27)

1. Papatsonis D.N.M., Van Geijn H.P., Adèr H.J., Lange F.M., Bleker O.P., Dekker G.A. Nifedipine and ritodrine in the management of preterm labor A randomized multicenter trial . Obstet Gynecol. 90:1997;230-234.
2. Holleboom C.A.G., Merkus J.M.W.M., van Elferen L.W.M. A loading-dose infusion scheme for intravenous tocolysis with ritodrine A pilot study . Eur J Obstet Gynecol Reprod Biol. 26:1987;119-126.
3. Volpe J.J. Intracranial hemorrhage. Volpe J.J. Neurology of the newborn. 3rd ed. 1995;403-466 WB Saunders Company, Philadelphia.
4. De Vries L.S., Eken P., Dubowitz L.M.S. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res. 49:1992;1-6.
5. Giedion A., Haefliger H., Dangel P. Acute pulmonary x-ray changes in hyaline membrane disease treated with artificial ventilation and positive end-expiratory pressure (PEP). Pediatr Radiol. 1:1973;145-152.
6. Ferguson J.E. II, Dyson D.C., Schutz T., Stevenson D.K. A comparison of tocolysis with nifedipine or ritodrine. Analysis of efficacy and maternal, fetal, and neonatal outcome. Am J Obstet Gynecol. 163:1990;105-111.
7. Meyer W.R., Randall H.W., Graves W.L. Nifedipine versus ritodrine for suppressing preterm labor. J Reprod Med. 35:1990;649-653.
8. Read M.D., Wellby D.E. The use of a calcium antagonist (nifedipine) to suppress preterm labour. Br J Obstet Gynaecol. 93:1986;933-937.
9. Kupferminc M., Lessing J.B., Yaron Y., Peyser M.R. Nifedipine versus ritodrine for supression of preterm labour. Br J Obstet Gynaecol. 100:1993;1090-1094.
10. Bracero L.A., Leikin E., Kirshenbaum N., Tejani N. Comparison of nifedipine and ritodrine for the treatment of preterm labor. Am J Perinatol. 8:1991;365-369.
11. Keirse M.J.N.C. Betamimetic tocolytics in preterm labour. Enkin M., Keirse M.J.N.C., Renfrew M.J., Neilson J.P. Pregnancy and childbirth module of the cochrane database of systematic reviews, (updated February 1995). 1995;BMJ Publishing Group, London.
12. Harake B., Gilbert R.D., Ashwal S., Power G.G. Nifedipine Effects on fetal and maternal hemodynamics in pregnant sheep . Am J Obstet Gynecol. 157:1987;1003-1008.
13. Ducsay C.A., Thompson J.S., Wu A.T., Novy M.J. Effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques Fetal plasma concentrations and cardiorespiratory changes . Am J Obstet Gynecol. 157:1987;1482-1486.
14. Furberg C.D., Psaty B.M., Meyer J.V. Nifedipine dose-related increase in mortality in patients with coronary heart disease. Circulation. 92:1995;1326-1331.
15. Pahor M., Guralnik J.M., Salive M.E., Corti M.C., Carbonin P., Havlik R.J. Do calcium channel blockers increase the risk of cancer? Am J Hypertens. 9:1996;695-699.
16. Pahor M., Guralnik J.M., Furberg C.D., Carbonin P.U., Havlik R.J. Risk of gastrointestinal hemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet. 347:1996;1061-1065.
17. Braun S., Boyko V., Behar S., Reicher-Reiss H., Shotan A., Schlesinger Z., et al. Calcium antagonist and mortality in patients with coronary artery disease. J Am Coll Cardiol. 28:1996;7-11.
18. Jick H., Jick S., Derby L.E., Vasilakis C., Myers M.W., Meier C.R. Calcium-channel blockers and risk of cancer. Lancet. 349:1997;525-528.
19. Olson J.H., Toft Sorensen H., Friis S., McLaughlin J.K., Steffensen F.H., Nielsen G.L., et al. Cancer risk in users of calcium channel blockers. Hypertension. 29:1997;1091-1094.
20. Ahr H.J., Bomhard E., Mager E., Schlüter G. Calcium channel blockers and cancer Is there preclinical evidence for an association? Cardiology. 88:(Suppl 3):1997;68-72.
21. Robertson P.A., Sniderman S.H., Laros R.K. Jr, Cowan R., Heilbron D., Goldenberg R.L., et al. Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 through 1986. Am J Obstet Gynecol. 166:1992;1629-1645.
22. Levene M.I., Fawer C.L., Lamont R.F. Risk factors in the development of intraventricular haemorrhage in the preterm neonate. Arch Dis Child. 57:1982;410-417.
23. Low J.A., Galbraith R.S., Sauerbrei E.E., Muir D.W., Killen H.L., Pater E.A., et al. Maternal, fetal and newborn complications associated with newborn intracranial hemorrhage. Am J Obstet Gynecol. 154:1986;345-351.
24. Lou H.C., Lassen N.A., Friis-Hansen B. Impaired autoregulation of cerebral blood flow in the distressed newborn infant. J Pediatr. 94:1979;118-121.
25. Groome L.J., Goldenberg R.L., Cliver S.P., Davis R.O., Copper R.L. Neonatal periventricular-intraventricular hemorrhage after maternal β-sympathomimetic tocolysis. The March of Dimes Multicenter Study Group. Am J Obstet Gynecol. 167:1992;873-879.
26. Dolfin T., Skidmore M.B., Fong K.W., Hoskin E.M., Milligan J.E., Moore D.C., et al. Perinatal factors that influence the incidence of subependymal and intraventricular hemorrhage in low birthweight infants. Am J Perinatol. 1:1984;107-113.
27. Laros R.K. Jr, Kitterman J.A., Heilbron D.C., Cowan R.M., Tooley W.H. Outcome of very-low-birth-weight infants exposed to β-sympathomimetics in utero. Am J Obstet Gynecol. 164:1991;1657-1665.